Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Wenjin Le"'
Publikováno v:
Pharmacology Research & Perspectives, Vol 10, Iss 3, Pp n/a-n/a (2022)
Abstract Advanced hepatocellular carcinoma (HCC) results in generally poor clinical outcomes and necessitates better therapeutic strategies. Ivermectin, which is an existing anti‐parasitic drug, has been recently identified as a novel anti‐cancer
Externí odkaz:
https://doaj.org/article/6331665e16d7449eb780c03a10671060
Publikováno v:
Cancer Chemotherapy and Pharmacology. 87:217-228
The survival benefit of sorafenib, the most used drug for advanced hepatocellular carcinoma (HCC), is unsatisfactory due to the development of adaptive resistance. Exploring the mechanisms underlying sorafenib resistance is important to develop sensi
Autor:
Haofeng, Lu, Lin, Zhou, Hongping, Zuo, Wenjin, Le, Jianfei, Hu, Tiequan, Zhang, Mi, Li, Yufeng, Yuan
Publikováno v:
Cancer chemotherapy and pharmacology. 87(2)
The survival benefit of sorafenib, the most used drug for advanced hepatocellular carcinoma (HCC), is unsatisfactory due to the development of adaptive resistance. Exploring the mechanisms underlying sorafenib resistance is important to develop sensi